2025
JCR Q1 · 3,7
313 matched articles
SCIE
Journal detail
Pathology Research and Practice (discontinued)
- Publisher
- Elsevier GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
0344033816180631
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR —
- Quartile -
- H-Index 78
- Cites/doc 3,79
- Docs (3y) 1.706
- Cites (3y) 6.048
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,7
- 5Y JIF 3,1
- JCI 1,17
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cell Biology
- Pathology and Forensic Medicine
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | — | Q1 | — | 3,7 | 3,1 | 1,17 | Q1 | 78 |
| 2024 | — | Q2 | — | 3,2 | 2,8 | 1,23 | Q1 | 72 |
| 2023 | Q2 | Q2 | 0,677 | 2,9 | 2,6 | 0,95 | Q2 | 72 |
| 2022 | Q2 | Q2 | 0,652 | 2,8 | 2,7 | 0,97 | Q2 | 72 |
| 2021 | Q2 | Q2 | 0,637 | 3,3 | 2,9 | 0,97 | Q2 | 72 |
| 2020 | Q2 | Q2 | 0,787 | 3,2 | 2,7 | 1,03 | Q2 | 72 |
| 2019 | Q2 | Q3 | 0,58 | 2 | 1,8 | 0,84 | Q2 | 72 |
| 2018 | — | Q3 | — | 1,8 | 1,6 | 0,76 | Q2 | — |
| 2017 | Q2 | Q3 | 0,547 | 1,5 | 1,5 | 0,62 | Q3 | 72 |
| 2016 | Q2 | Q3 | 0,654 | 1,5 | 1,5 | — | — | 72 |
| 2015 | Q2 | Q3 | 0,63 | 1,4 | 1,4 | — | — | 72 |
| 2014 | Q2 | Q3 | 0,649 | 1,4 | 1,4 | — | — | 72 |
| 2013 | Q2 | Q3 | 0,643 | 1,6 | 1,4 | — | — | 72 |
| 2012 | Q2 | Q4 | 0,609 | 1,2 | 1,3 | — | — | 72 |
| 2011 | Q2 | Q3 | 0,588 | 1,2 | 1,2 | — | — | 72 |
| 2010 | Q2 | Q3 | 0,515 | 1,3 | 1,3 | — | — | 72 |
| 2009 | — | Q3 | — | 1,2 | 1,1 | — | — | — |
| 2008 | — | Q4 | — | 1 | 1,2 | — | — | — |
| 2007 | — | Q4 | — | 1,1 | 1,1 | — | — | — |
| 2006 | — | Q4 | — | 0,9 | — | — | — | — |
| 2005 | — | Q3 | — | 1 | — | — | — | — |
| 2004 | — | Q4 | — | 0,7 | — | — | — | — |
| 2003 | — | Q4 | — | 0,8 | — | — | — | — |
| 2002 | — | Q4 | — | 0,8 | — | — | — | — |
| 2001 | — | Q2 | — | 1,2 | — | — | — | — |
| 2000 | — | Q3 | — | 1,1 | — | — | — | — |
| 1999 | — | Q4 | — | 0,7 | — | — | — | — |
| 1998 | — | Q2 | — | 1,1 | — | — | — | — |
| 1997 | — | Q3 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PATHOLOGY | SCIE | Q1 | Q1 | 20/89 |
| 2024 | PATHOLOGY | SCIE | Q2 | Q1 | 23/90 |
| 2023 | PATHOLOGY | SCIE | Q2 | Q2 | 28/88 |
| 2022 | PATHOLOGY | SCIE | Q2 | Q2 | 37/76 |
| 2021 | PATHOLOGY | SCIE | Q2 | Q2 | 36/77 |
| 2020 | PATHOLOGY | SCIE | Q2 | Q2 | 33/77 |
| 2019 | PATHOLOGY | SCIE | Q3 | Q2 | 43/78 |
| 2018 | PATHOLOGY | SCIE | Q3 | Q2 | 45/76 |
| 2017 | PATHOLOGY | SCIE | Q3 | Q3 | 55/79 |
| 2016 | PATHOLOGY | SCIE | Q3 | — | 53/79 |
| 2015 | PATHOLOGY | SCIE | Q3 | — | 55/79 |
| 2014 | PATHOLOGY | SCIE | Q3 | — | 57/76 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 54/76 |
| 2012 | PATHOLOGY | SCIE | Q4 | — | 59/77 |
| 2011 | PATHOLOGY | SCIE | Q3 | — | 58/79 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 53/76 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 52/71 |
| 2008 | PATHOLOGY | SCIE | Q4 | — | 57/69 |
| 2007 | PATHOLOGY | SCIE | Q4 | — | 53/66 |
| 2006 | PATHOLOGY | SCIE | Q4 | — | 50/64 |
| 2005 | PATHOLOGY | SCIE | Q3 | — | 45/66 |
| 2004 | PATHOLOGY | SCIE | Q4 | — | 54/65 |
| 2003 | PATHOLOGY | SCIE | Q4 | — | 54/64 |
| 2002 | PATHOLOGY | SCIE | Q4 | — | 51/64 |
| 2001 | PATHOLOGY | SCIE | Q2 | — | 31/66 |
| 2000 | PATHOLOGY | SCIE | Q3 | — | 39/67 |
| 1999 | PATHOLOGY | SCIE | Q4 | — | 50/66 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 28/68 |
| 1997 | PATHOLOGY | SCIE | Q3 | — | 45/66 |